Author

Martinus Anderegg 1

1 Academic Medical Center

PET-CT AFTER NEOADJUVANT CHEMORADIOTHERAPY CAN PREVENT NON-CURATIVE SURGICAL INTERVENTIONS FOR ESOPHAGEAL CANCER PATIENTS

Martinus Anderegg, Suzanne S. Gisbertz, Roel Bennink, Jacques J. Bergman, Mark Ivo van Berge Henegouwen

PET-CT AFTER NEOADJUVANT CHEMORADIOTHERAPY CAN PREVENT NON-CURATIVE SURGICAL INTERVENTIONS FOR ESOPHAGEAL CANCER PATIENTS

Martinus Anderegg

SURVIVAL AFTER PATHOLOGIC COMPLETE RESPONSE IN PATIENTS WITH CANCER OF THE ESOPHAGUS OR GASTRO-ESOPHAGEAL JUNCTION

Martinus Anderegg, Wernard Borstlap, Suzanne S. Gisbertz, Sybren L. Meijer, Jacques J. Bergman, Hanneke van Laarhoven

THE IMPACT OF LYMPH NODE METASTASIS NEAR THE CELIAC TRUNK IN PATIENTS WITH CANCER OF THE DISTAL ESOPHAGUS OR GASTRO-ESOPHAGEAL JUNCTION

Martinus Anderegg, Suzanne S. Gisbertz, Sybren L. Meijer, Jacques J. Bergman, Hanneke van Laarhoven

THE PROGNOSTIC VALUE OF A MODIFIED TUMOUR REGRESSION GRADE AFTER NEOADJUVANT CHEMORADIOTHERAPY AND RESECTION OF OESOPHAGEAL CARCINOMA

Martinus Anderegg, Sjoerd M Lagarde, Wernard Borslap, Suzanne S. Gisbertz, Sybren L. Meijer, Maarten Hulshof, Jacques J. Bergman, Hanneke van Laarhoven

THE RELEVANCE OF THE LOCATION OF INVOLVED NODES IN PATIENTS WITH CANCER OF THE DISTAL ESOPHAGUS OR GASTRO-ESOPHAGEAL JUNCTION

Martinus Anderegg, Suzanne S. Gisbertz, Sybren L. Meijer, Jacques J. Bergman, Hanneke van Laarhoven

TUMOR STROMA RATIO (TSR) IN ESOPHAGEAL ADENOCARCINOMA BIOPSIES IN THE PREDICTION OF RESPONSE TO NEOADJUVANT THERAPY AND OVERALL SURVIVAL

Charlotte Hetterschijt, Rachel Blom, Martinus Anderegg, Hanneke van Laarhoven, Sybren L. Meijer, Suzanne S. Gisbertz

Item 1 - 7 / 7
1